Skip to main content
. 2020 Nov 6;35(Suppl 2):ii74–ii83. doi: 10.1093/heapol/czaa125

Table 4.

Examples of actor interfaces and practices of power in JSSK implementation

Example of interfaces observed Practices of power and related implementation issue
Political interfaces (centre-state/politician-managers/managers-private owners) Centre domination on policy and programmatic agenda over the decision of JSSK rollout in HP

Resistance and contestations by private service providers against free medicines and tests in public hospitals

Negotiations by managers with private providers

Interfaces among middle managers across levels (facility/district/state)

Resistance by facility managers to follow top down instructions on JSSK documentation and reporting

Contestation for getting credit about delivering free services among state and district managers

State domination over reporting needs

Collaboration for local problem solving and implementation needs for policy among some managers
Top down push by state to control implementation steps and guidelines, Resistance and avoidance by facility managers
Interfaces among doctors and managers in health facilities

Resistance of doctors towards a restrictive medicine list; Resistance of doctors for using generic drugs

Negotiations and contestations from doctors about need of higher end and more modern medicines citing quality issues

Resistance related to prescription of ultrasonography to pregnant women
Resistance from doctors for involvement in national programmes
Interfaces among nurses and managers health facilities

Control of administrators on resources

Negotiations by nurses for availability of medicines

Contestation and negotiation by nurses with doctors on choice of free medicines and tests for patients
Interfaces among beneficiaries and service providers (doctors/nurses/managers) Doctors facilitation for service delivery to clients
Domination of doctors and nurses on service delivery decisions (sending a client away)
Domination of doctors on patient’s choice for medicines or treatment and consent from patients
Negotiations and contestations of beneficiary and managers for better quality or more advanced services or services bypassing the guidelines
Doctor and service provider control over providing USG service and client negotiations for USG service access